Century Therapeutics Inc (IPSC) — Cash Flow-to-Debt Ratio
Century Therapeutics Inc (IPSC) has a Cash Flow-to-Debt Ratio of -0.25x as of December 2025, meaning its operating cash flow of $-16.08 Million could theoretically repay 0% of its total liabilities ($64.77 Million) in one year. See IPSC free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Century Therapeutics Inc Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Century Therapeutics Inc across 8 annual periods. Also explore IPSC net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Century Therapeutics Inc (2015–2025)
Year-by-year debt coverage analysis for Century Therapeutics Inc. For market capitalisation and broader financial context, see Century Therapeutics Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.60x | $-103.88 Million | $64.77 Million | ▼ -179.4% |
| 2024 | -0.57x | $-110.14 Million | $191.85 Million | ▼ -14.3% |
| 2023 | -0.50x | $-88.35 Million | $175.94 Million | ▼ -756.8% |
| 2022 | 0.08x | $14.05 Million | $183.81 Million | ▲ +103.5% |
| 2021 | -2.16x | $-89.00 Million | $41.14 Million | ▼ -1017.7% |
| 2020 | -0.19x | $-41.27 Million | $213.19 Million | ▼ -118.8% |
| 2019 | -0.09x | $-16.17 Million | $182.75 Million | ▼ -141.1% |
| 2015 | 0.22x | $104.30 Million | $484.99 Million | — |